Moderna’s CEO predicts the firm’s shot could get emergency FDA approval by December
Moderna Inc says it will know if its experimental coronavirus vaccine is effective at preventing people from contracting the disease by November. CEO Stéphane Bancel, speaking at The Wall Street Journal’s annual Tech Live conference, said the company is waiting for interim results of its late-stage clinical trial. Provided the results are positive, Moderna could apply … Read more